Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of the American College of Cardiology

• Publication date

  1996-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(96)00109-XPMID 8752787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Calcium antagonists: when the content does not justify the headline

  1995cited by this paper
• The calcium channel blocker scare. Lessons for the future.

  1995cited by this paper
• Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

  1995cited by this paper
• Case-Control Study, Meta-analysis, and Bouillabaisse: Putting the Calcium Antagonist Scare into Context

  1995cited by this paper
• Nifedipine and mortality. Grave defects in the dossier.

  1995cited by this paper
• The risk of myocardial infarction associated with antihypertensive drug therapies.

  1995cited by this paper
• Nifedipine in ischemic heart disease.

  1995cited by this paper
• Calcium antagonists in the management of systemic hypertension: the impact of sustained‐release drug‐delivery systems

  1994cited by this paper
• Usefulness of amlodipine for angina pectoris.

  1994cited by this paper
• Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.

  1993cited by this paper
• Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).

  1993cited by this paper
• Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

  1991cited by this paper
• Calcium antagonist caution.

  1991cited by this paper
• Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

  1990cited by this paper
• Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris.

  1990cited by this paper
• The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy.

  1989cited by this paper
• The effect of diltiazem on mortality and reinfarction after myocardial infarction.

  1989cited by this paper
• Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

  1989cited by this paper
• Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.

  1986cited by this paper
• Use of calcium channel blocking agents in the management of ischaemic heart disease.

  1985cited by this paper
• Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

  1984cited by this paper
• Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.

  1984cited by this paper
• Production of ischaemic cardiac pain by nifedipine.

  1978cited by this paper

• The Fontan/Kreutzer Procedure: A Case Report

  2016cites this paper
• Role of dihydropyridinic calcium channel blockers in the management of hypertension

  2013cites this paper
• What Is Pharmacoepidemiology?

  2013cites this paper
• Meta analysis and meta regression of a measure of discrimination used in prognostic modeling

  2013cites this paper
• 1. What is Pharmacoepidemiology

  2012cites this paper
• Relationship Between Body Mass and Blood Pressure in Diverse Populations

  2012cites this paper
• disease. Benzafibrate Infarction Prevention (BIP) Study Research Group Calcium channel blocking agents and risk of cancer in patients with coronary heart

  2011cites this paper
• Weight-height relationships and body mass index: some observations from the Diverse Populations Collaboration.

  2005cites this paper
• Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies.

  2005cites this paper
• Update on the controversies of tocolytic therapy for the prevention of preterm birth

  2004cites this paper
• Klinik und aktuelle Therapie des hypertensiven Notfalls -Erwiderung

  2004cites this paper
• Calcium antagonists.

  2004cites this paper
• Calcium channel blockers and hypertension: Evolving perspectives—1996

  2004cites this paper
• Prior Calcium Channel Blockade and Short-Term Survival Following Acute Myocardial Infarction

  2004cites this paper
• Klinik und aktuelle Therapie des hypertensiven Notfalls

  2003cites this paper
• Hypertension in the critically ill patient.

  2003cites this paper
• Effect of Intracoronary Estradiol on Postischemic Microvascular Damage in a Porcine Model: A Myocardial Contrast Echocardiographic Study

  2003cites this paper
• The use of calcium antagonists in the therapy of hypertension in the elderly.

  2003cites this paper
• Calcium Channel Antagonists in the Treatment of Hypertension

  2002cites this paper
• Diabetes mellitus and cardiovascular disease.

  2002cites this paper
• A Randomized, Double-Blind Comparison of 10 and 20 mg Lercanidipine in Patients With Stable Effort Angina: Effects on Myocardial Ischemia and Heart Rate Variability

  2002cites this paper
• Lactacidosis in the neonate is minimized by prenatal detection of congenital heart disease

  2002cites this paper
• The treatment of adults with essential hypertension.

  2002cites this paper
• Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patientst.

  2001cites this paper
• Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards.

  2001influential citation
• Calcium channel blockers in the management of preterm labor and hypertension in pregnancy.

  2001cites this paper
• Meta-analyses of antihypertensive therapy: Are some of them misleading?

  2001cites this paper
• The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection?

  2001influential citation
• Tratamiento de la angina estable

  2001cites this paper
• Die medikamentöse Therapie der stabilen Angina pectoris

  2001cites this paper
• Peri‐operative silent myocardial ischaemia and long‐term adverse outcomes in non‐cardiac surgical patients*

  2001cites this paper
• Cancer risk and mortality in users of calcium channel blockers

  2000cites this paper
• A comparison of observational studies and randomized, controlled trials.

  2000cites this paper
• Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia.

  2000cites this paper
• A male autopsy case of autoimmune hepatitis complicated with hepatocellular carcinoma.

  2000cites this paper
• β-adrenoceptor antagonists and antianginal drugs

  2000cites this paper
• Calcium Antagonists and Calcium Sensitizers

  2000cites this paper
• Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP)

  2000cites this paper
• Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.

  2000cites this paper
• Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture

  2000cites this paper
• Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration

  2000cites this paper
• A comparison of observational studies and randomized, controlled trials

  2000cites this paper
• The calcium‐channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology ‘hot topic’

  2000cites this paper
• Neonatal Effects of Nifedipine and Ritodrine for Preterm Labor

  2000cites this paper
• Confounding by indication: the case of calcium channel blockers

  2000cites this paper
• Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty.

  1999cites this paper
• Sudden cardiac death.

  1999cites this paper
• Calcium channel blockers and mortality in elderly patients with myocardial infarction.

  1999cites this paper
• Incidence of cancer in postmyocardial infarction patients treated with short‐acting nifedipine and diltiazem

  1999cites this paper
• Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.

  1999cites this paper
• Calcium channel blockers: current controversies and basic mechanisms of action.

  1999cites this paper
• Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists.

  1999cites this paper
• [Advances in the treatment of hypertension].

  1999cites this paper
• [The adverse effects of drugs: the hidden part of the iceberg].

  1999cites this paper
• Application of calcium channel blockers in the treatment of cardiovascular diseases.

  1999cites this paper
• Current status of calcium channel blockers in patients with cardiovascular disease.

  1999cites this paper
• Hypertension in the elderly and calcium antagonists

  1999cites this paper
• Choosing between randomised and non-randomised studies: a systematic review.

  1998cites this paper
• Calcium Channel Blocking Agents and Risk of Cancer in Patients With Coronary Heart Disease 11This study was supported by Boehringer-Mannheim Ltd., Mannheim, Germany.

  1998cites this paper
• The safety of calcium-channel blockers.

  1998cites this paper
• Is the Use of Some Calcium Antagonists Linked to Cancer?

  1998cites this paper
• Meta-analysis of Nifedipine versus Beta-sympathomimetic Agents for Tocolysis during Preterm Labour

  1998cites this paper
• Calcium Antagonists and Cancer

  1998cites this paper
• The calcium antagonist controversy: a posthumous commentary.

  1998cites this paper
• Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.

  1998cites this paper
• Acute Myocardial Infarction Mortality Related to Use of Calcium Antagonists Before Admission to Hospital

  1998cites this paper
• Potential biases in assessing the risks of pharmacotherapy due to mismeasurement of drug exposure.

  1998cites this paper
• Treatment of Angina Pectoris with Calcium Antagonists: Long-Term Follow-up

  1998cites this paper
• Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.

  1998cites this paper
• ANTIHYPERTENSIVE PRESCRIBING AND RISK OF ADVERSE EVENTS IN A FEMALE MEDICAID POPULATION

  1998cites this paper
• Calcium antagonists and mortality risk in men and women with hypertension in the Framingham Heart Study.

  1998cites this paper
• Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

  1998cites this paper
• A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond

  1998cites this paper
• Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers.

  1997cites this paper
• Evaluating the association between drug use and outcome--should the information from observational studies affect therapeutic use?

  1997cites this paper
• Safety of calcium channel blockers: perspective on the controversy.

  1997cites this paper
• Cardiac effects of combination therapy.

  1997cites this paper
• Primary prevention of cardiovascular disease.

  1997cites this paper
• Calcium antagonists in cardiovascular disease: a necessary controversy but an unnecessary panic.

  1997cites this paper
• Calcium channel blockers: an evidence-based review.

  1997cites this paper
• Calcium channel blockers: association with myocardial infarction, mortality, and cancer.

  1997cites this paper
• A personal view of the controversy regarding the use of calcium channel blockers in hypertension

  1997cites this paper
• Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad hoc subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.

  1997cites this paper
• Treatment of hypertension in the elderly

  1997cites this paper
• Diversity of calcium antagonists.

  1997cites this paper
• Accumulating scientific evidence in cardiology with special reference to the Japanese contribution.

  1997cites this paper
• Pharmaceutical economics & health policy

  1997cites this paper
• Are calcium antagonists proarrhythmic?

  1997cites this paper
• The calcium channel blocker controversy in 1997.

  1997cites this paper
• [Calcium antagonists in ischemic heart disease].

  1997cites this paper
• Cardiac effects of calcium antagonists in systemic hypertension.

  1997cites this paper
• Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding

  1997cites this paper
• The emergence of case‐control studies in hypertension research: valid or misleading?

  1997cites this paper
• Use of calcium antagonists in patients with ischemic heart disease and systemic hypertension.

  1997cites this paper
• Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality.

  1997cites this paper
• Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.

  1997cites this paper
• Calcium-antagonist controversy: the long and short of it?

  1997cites this paper
• Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions.

  1997cites this paper
• NEW INSIGHTS INTO THE TREATMENT OF HYPERTENSION

  1997cites this paper
• Calcium antagonists did not increase mortality in patients with coronary artery disease

  1997cites this paper